Eli Lilly’s (LLY) Loxo and Foghorm (FHTX) Collaborate for Novel Oncology Targets using Foghorn’s Gene Traffic Control Platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: FHTX) | Delayed: 1.95 -0.05 (2.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $ | |||
| Open | $1.98 | 52 Week Low | $ | |||
| Day High | $2.00 | P/E | N/A | |||
| Day Low | $1.94 | EPS | $ | |||
| Volume | 586,298 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1182.62 +3.35 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1179.27 | 52 Week High | $88.16 | |||
| Open | $1181.24 | 52 Week Low | $67.88 | |||
| Day High | $1188.70 | P/E | 273.75 | |||
| Day Low | $1172.81 | EPS | $4.32 | |||
| Volume | 1,251,808 | |||||
